Tag Archives: specialty pharmaceutical

ValoremRx Adds New Member, Kroger Specialty Pharmacy

ValoremRx Specialty Solutions, the group purchasing organization (GPO) formed by a joint venture between Express Scripts and Walgreens, recently announced its new collaboration with Kroger Specialty Pharmacy. Express Scripts and Walgreens Boots Alliance broadened their purchasing efforts in 2018 to include specialty brand drugs. Partnered with Express Scripts’ specialty pharmacy Accredo® and Walgreens’ specialty pharmacy […]

Biologics to Play Leading Role in McKesson’s Strategy

McKesson Corporation announced a multi-year strategic growth initiative in 2018, focused on creating innovative new solutions that improve patient care delivery and drive incremental profit growth. The initiative comprises multiple growth pillars, and includes a comprehensive review of the company’s operations and cost structure, designed to increase efficiency, accelerate execution and improve long-term performance. McKesson’s […]

The specialty pharmaceutical hub market continues to evolve entering 2019 with new entrants, investment, and consolidation

Specialty Pharmaceutical Hub Services Providers 2019 Report

Employers Use of Copay Accumulator Programs is Growing

man looking at virtual customers

Walmart and Home Depot, two of the top 10 U.S. employers, are using copay accumulator programs

Specialty Pharmacy Market Overview – Market Shakeout Continuing into 2018

Specialty Pharmacy Market Overview – Market Shakeout Continuing into 2018 As the specialty drug spend grows, specialty pharmacies are playing an increasingly larger role in access and delivery of medications and services. The specialty pharmacy market, while dominated by a few large companies, has an increasing number of participants. AMI’s annual report, Specialty Pharmacy Market […]

Specialty Drug Wave Hitting Medical and Pharmacy Plans Harder: Trends versus reliable benefit strategy to handle the impact through 2020?

Specialty Drug Wave Hitting Medical and Pharmacy Plans Harder: Trends versus reliable benefit strategy to handle the impact through 2020?The U.S. now has two different markets resulting from implementation of the Affordable Care Act (ACA) and resultant trends. Related to specialty or biological drugs, public sector CMS’s forecast of drug spending is somewhat counterintuitive, given […]

Hepatitis C and Specialty Pharmacy Market

Express Scripts Plans a Specialty Drug Price War over new hepatitis C treatments reports a recent Bloomberg News story. The news follows the release of Gilead’s Sovaldi (sofosbuvir), which reportedly costs $1,000 per pill. Express Scripts projects that Hepatitis C drug trend will grow by 168% by 2015, so employers and health plan payers are […]